A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Jonas Hugosson, Monique J. Roobol, Marianne Månsson, Teuvo L.J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Sigrid V. Carlsson, Kirsi M. Talala, Hans Lilja, Louis J. Denis, Franz Recker, Alvaro Paez, Donella Puliti, Arnauld Villers, Xavier Rebillard, Tuomas P. Kilpeläinen, Ulf H. Stenman, Rebecka Arnsrud GodtmanKarin Stinesen Kollberg, Sue M. Moss, Paula Kujala, Kimmo Taari, Andreas Huber, Theodorus van der Kwast, Eveline A. Heijnsdijk, Chris Bangma, Harry J. De Koning, Fritz H. Schröder, Anssi Auvinen

Research output: Contribution to journalArticlepeer-review

Abstract

This European Randomized study of Screening for Prostate Cancer trial follow-up reports that repeated screening reduces the risk of dying from prostate cancer for up to 16 yr.

Original languageEnglish
Pages (from-to)43-51
JournalEuropean Urology
Volume76
Issue number1
Early online date2019 Feb 26
DOIs
Publication statusPublished - 2019

Subject classification (UKÄ)

  • Cancer and Oncology
  • Urology and Nephrology
  • Public Health, Global Health, Social Medicine and Epidemiology

Keywords

  • Mortality
  • Prostate cancer
  • Prostate-specific antigen
  • Screening

Fingerprint

Dive into the research topics of 'A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer'. Together they form a unique fingerprint.

Cite this